News

A survey by Express Scripts shows that patients tend to think that they are more compliant than they are.

Healthcare experts say a move away from the fee-for-service payment model can't happen too soon.

Support school nurses who can improve kids' health.

Providers, especially primary care physicians, are struggling to meet increasing demands.

Few consumers are able to find adequate cost and quality information that truly helps them make cost-conscious healthcare decisions

Sure, you need to eat right and exercise, but why aren't you doing it?

With health reform transforming the industry, a study from the Employee Benefit Research Institute (EBRI) shows the current realities of employer-based care.

Well-constructed data integration strategies can help manage the swelling data flood.

A policy requirement that employers with more than 200 full-time employees must enroll their employees in a company health plan may not take effect until 2015.

Congress wants to get serious about fixing the Medicare formula for reimbursing physicians, an initiative that would affect healthcare rates and expenditures more broadly.

Providers pledge to drive out waste by avoiding certain unnecessary services, and many believe it's a good first effort at true cost control.

Program for Afib patients could provide template of improved outcomes.

Medicare Advantage's star rating program includes overly ambitious benchmarks.

The use of benzocaine gels and liquids to soothe teething and mouth and gum pain can lead to a rare but serious?and sometimes fatal?condition called methemoglobinemia, according to an FDA Consumer Update.

The drug-shortage crisis got a step closer to being alleviated Thursday, when the U.S. Senate passed FDA?s Safety and Innovation Act (SB-3187).

The use of atypical antipsychotics in patients with major depressive disorder who have not responded to antidepressant therapy substantially increased clinical response rates at 6 weeks; however the drugs are also much more costly, according to the results of an analysis published in the May issue of The Annals of Pharmacotherapy.

The multiple sclerosis drug fingolimod (Gilenya, Novartis) is now contraindicated for use in patients with certain pre-existing or recent heart conditions or stroke, or who are taking certain antiarrhythmic medications, according to FDA

Taking probiotics during a course of antibiotics reduces the risk of antibiotic-associated diarrhea, according to the results of a study published May 9 in the Journal of the American Medical Association.

The Affordable Care Act saved Medicare recipients more than $3 billion on prescription drugs and 12.1 million recipients used a free preventive service in the first four months of 2012, the government said in a news release today

FDA has notified healthcare professionals that it is aware of a study published in the New England Journal of Medicine reporting a small increase in cardiovascular deaths and in the risk of death from any cause in persons treated with a 5-day course of azithromycin (Zithromax) compared to persons treated with amoxicillin, ciprofloxacin, or no drug.

FDA has approved generic versions of clopidogrel tablets USP (Plavix, Sanofi and Bristol-Myers Squibb), 75 mg and 300 mg.

A law that took effect in December would allow insurers to sell policies across state lines has no takers. The law was supposed to allow the free market to lower prices and increase choice.

Despite the fact that the federal government has not approved requests to waive a number regulations that would thwart it, Kansas is moving ahead with its KanCare Medicaid overhaul

Great American Supplemental Benefits Group, one of the largest manufacturers, distributors, and marketers of supplemental health insurance products in the United States, is being acquired by Cigna Corporation for around $295 million in cash

The ability of adults to obtain basic healthcare services in the United States has declined in nearly every state over the last decade, especially among those without insurance, according to a report by the Robert Wood Johnson Foundation (RWJF).

UnitedHealthcare is offering SignatureValue Alliance in California, a new health benefits plan that features what it calls "high-performance" care provider networks aimed at delivering effective, evidence-based and cost-efficient care

Hospira is voluntarily recalling one lot of hydromorphone injection, USP, 1 mg/mL (C-II), 1-mL fill in 2.5-mL Carpuject, NDC 0409-1283-31, after complaints that a single Carpuject contained more than the 1-mL labeled fill volume, according to a press release posted on the FDA website.

Pharmacists need additional guidance on the handling of biosimilar products in the pharmacy when these products become more widely available following the approval of the biosimilar pathway, said Marcie Bough, senior director of government affairs, APhA, speaking at an FDA hearing last week.